Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Bezlotoxumab - in "Real Life" - During the First Episode of Clostridium Difficile Infection in Patients With High Risk of Recurrence. BEFORE Study

NCT04075422 is registered in ClinicalTrials.gov with Fundacion SEIMC-GESIDA as lead sponsor.

NCT NCT04075422
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04075422 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Bezlotoxumab - in "Real Life" - During the First Episode of Clostridium Difficile Infection in Patients With High Risk of Recurrence. BEFORE Study
Lead sponsor
Fundacion SEIMC-GESIDA
Phase
Observational
Overall status
Completed
Start date
October 1, 2019
Completion date
October 28, 2022
Enrollment
869 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

clostridium difficile infection